| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 75.72M | 77.34M | 84.27M | 83.68M | 79.71M | 51.10M |
| Gross Profit | 22.62M | 22.13M | 21.18M | 20.91M | 24.37M | 16.13M |
| EBITDA | -402.00K | -2.27M | -14.19M | -11.98M | 9.14M | 1.99M |
| Net Income | -7.30M | -9.15M | -20.37M | -19.00M | 2.50M | -2.23M |
Balance Sheet | ||||||
| Total Assets | 56.16M | 66.89M | 82.94M | 115.12M | 125.67M | 104.47M |
| Cash, Cash Equivalents and Short-Term Investments | 0.00 | 4.65M | 8.88M | 6.77M | 7.91M | 5.73M |
| Total Debt | 8.00M | 14.47M | 17.77M | 25.79M | 19.31M | 13.44M |
| Total Liabilities | 17.56M | 27.56M | 35.11M | 48.44M | 46.99M | 43.82M |
| Stockholders Equity | 38.60M | 39.33M | 47.84M | 66.69M | 78.68M | 60.65M |
Cash Flow | ||||||
| Free Cash Flow | 2.24M | 1.43M | 7.33M | -2.37M | 6.14M | 5.18M |
| Operating Cash Flow | 2.25M | 1.43M | 7.54M | -1.79M | 6.68M | 5.64M |
| Investing Cash Flow | -8.00K | 89.00K | 5.88M | -2.68M | -8.01M | -11.53M |
| Financing Cash Flow | -7.52M | -5.81M | -11.23M | 3.35M | 3.69M | 6.92M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | £2.43B | 10.91 | 42.93% | 2.05% | 51.50% | 11.62% | |
72 Outperform | £50.55M | 14.63 | 38.65% | 2.69% | 30.01% | 138.65% | |
69 Neutral | £53.37M | 15.19 | 12.27% | ― | 20.40% | ― | |
68 Neutral | £3.23B | 20.00 | 17.42% | 2.43% | 21.86% | 0.86% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
54 Neutral | £185.60M | 18.70 | 4.57% | 3.01% | -31.46% | 297.44% | |
52 Neutral | £29.55M | -2.77 | -18.74% | ― | -5.84% | 55.30% |